Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Sedláková, I."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vladimir Palicka, Marcela Chmelarova, Sedláková I, Jan Laco, Filip Vrbacky, Petr Hejna, Helena Kovarikova, Dalibor Kovarik, Ivana Baranova
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 58:1332-1340
Background The lack of effective biomarkers for the screening and early detection of ovarian cancer (OC) is one of the most pressing problems in oncogynecology. Because epigenetic alterations occur early in the cancer development, they provide great
Publikováno v:
In Toxicology in Vitro 2010 24(8):2108-2115
Autor:
Vladimir Palicka, Marcela Chmelarova, Sedláková I, Ondrej Dvorak, Ivana Baranova, Helena Kovarikova, Jan Laco
Publikováno v:
Cancer Biomarkers. 23:125-133
Background Aberrant DNA methylation of protocadherins (PCDHs) has been associated with development and progression of various types of cancer. It could represent possible direction in the search for critically needed tumor biomarkers for ovarian canc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Europe PubMed Central
Evaluation of importance of serum levels of basic fibroblast growth factor (bFGF) in patients with ovarian cancer, patients with border-line ovarian tumor, patients with benign ovarian cyst and women with normal ovarian tissue.Prospective clinical st
Autor:
Jindrich Kopecky, Doris Vokurková, Otakar Kopecky, Jindrich Tosner, Sedláková I, Vladimira Vroblova, Šárka Lukešová, Eva Cermakova
Publikováno v:
Contemporary Oncology
Aim of the study A number of observations have indicated that the immune system plays a significant role in patients with epithelial ovarian cancer (EOC). In cases of EOC, the prognostic significance of tumour infiltrating lymphocytes has not been cl
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 29(5)
This study was designed to compare the expression of PgP (P-glycoprotein), MRP1 (multidrug related protein), and MRP3 in ovarian cancer patients, patients with benign ovarian tumors, and healthy women, and to evaluate the correlation between the expr
Publikováno v:
Clinical Ovarian Cancer. 3:41-46
Purpose: We seek to compare lysophosphatidic acid (LPA) plasma levels (all subtypes) in patients with ovarian cancer and patients without this disease. Patients and Methods: Capillary electrophoresis with indirect ultraviolet detection was used to an
Publikováno v:
Czech Gynaecology / Česká Gynekologie; 2018, Vol. 83 Issue 3, p169-176, 8p